4-HO-DiPT
4-hydroxy-N,N-diisopropyltryptamine
1Provenance card
the boundary, as counts
Sources
2216 with DOI
4 strong · 12 moderate · 6 weak
Compilations
12026-04-26T14:55:21.968Z
pipeline-v5 · prompt hash not recorded — run predates 2026-09
Decisions
30last ruled 2026-06-04
0 awaiting a ruling
Issued documents
62026-10-19T20:29:57.389Z
notice · info card · emergency
Searches
193 with no results
queries and counts on the build
Claims checked
5135 supported
35 supported · 16 not
Correspondence
0received
consent field ships in Phase 4
Edges
190
derivations recorded for this entity
Complete over 22 sources, 1 compilation, and 30 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/4-ho-dipt/archive
Timeline
what happened, newest first — claims, searches and artifacts stay inside Build
- 2026-10-19issueIssued emergency
- 2026-10-19issueIssued info_card
- 2026-10-19issueIssued notice
- 2026-09-24srcMetabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine
- 2026-09-24srcPsilocin analogs. 1. Synthesis of 3-[2-(dialkylamino)ethyl]-and 3-[2-(cycloalkylamino)ethyl] indol-4-ols
- 2026-09-24srcOpioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects
- 2026-09-24srcDesigner drugs: mechanism of action and adverse effects
- 2026-09-24srcReceptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
- 2026-09-24srcRE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-N,N-diisopropyltryptamine
- 2026-09-24srcInvestigation of the Structure-Activity Relationships of Psilocybin Analogues
- 2026-09-24srcReceptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy-N,N-dimethyltryptamine in Mice
- 2026-09-24srcPsilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdala
- 2026-09-24srcPsychedelics promote plasticity by directly binding to BDNF receptor TrkB
- 2026-09-24srcSynthesis and structure of 4-hydroxy-N-isopropyltryptamine (4-HO-NiPT) and its precursors
- 2026-09-24srcBenefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression
- 2026-09-24srcIndolealkylamines: biotransformations and potential drug-drug interactions
- 2026-09-24srcRecreational use, analysis and toxicity of tryptamines.
- 2026-09-24srcHuman Hepatocyte 4-Acetoxy-N,N-Diisopropyltryptamine Metabolite Profiling by LC-HRMS/MS
- 2026-09-24srcMultimechanistic Single-Entity Combinations for Chronic Pain Control: A Narrative Review.
- 2026-09-24srcSchedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine — Withdrawal of Proposed Rule
- 2026-09-24src4-Hydroxy-N,N-diisopropyltryptamine - Wikipedia
- 2026-09-24srcPharmacologic Activity Review: 4-HO-DiPT
- 2026-09-24srcRE104 Safety and Efficacy Study in Postpartum Depression (RECONNECT)
- 2026-09-24srcU.S. FDA Grants Reunion Neuroscience's Luvesilocin (RE104) Breakthrough Therapy Designation Status
- 2026-09-24srcTiHKAL #17: 4-HO-DIPT
- 2026-09-04issueIssued emergency
- 2026-09-04issueIssued info_card
- 2026-09-04issueIssued notice
- 2026-06-04proposal28 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
- 2026-06-04publicationPublication — backfill
- 2026-04-26revisionRevision 1
- 2026-04-26absenceSearched PubMed for "4-hydroxy-N-isopropyltryptamine 4-HO-NiPT synthesis structure metabolite tryptamine" — no results
- 2026-04-26absenceSearched PubMed for "4-hydroxy diisopropyltryptamine serotonin receptor binding pharmacology" — no results
- 2026-04-26absenceSearched ClinicalTrials.gov for "4-HO-DiPT diisopropyltryptamine" — no results
- 2026-04-26genGeneration — pipeline-v5pipeline-v5
- 2026-04-26rungeneration run
The same entries, as forms: six forms.